Back to discover
Drug

Magnesium

In clinical development
Emerging researchLate-stage developmentRising momentum
Also known as Mg, Magnesio, Elemental Magnesium, Magnesium metallicum+2 more

Mg, Magnesio, Elemental Magnesium, Magnesium metallicum, Magnésium, Mg - Magnesium.

10
Research papers
9
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Pharmacological Management of Post Operative Shivering Following Anesthesia

Clinical trial2026-07-01Primary completion · ClinicalTrials.gov

Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures

Clinical trial2026-06-30Primary completion · ClinicalTrials.gov

Multimodal Nonopioid Pain Protocol Following Shoulder Arthroplasty Surgery

Clinical trial2026-02-10Results posted · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Magnesium
Aliases & brands
MgMagnesioElemental MagnesiumMagnesium metallicumMagnésiumMg - Magnesium
RxNorm CUI
6574
ChEMBL ID
CHEMBL1201230
UNII
I38ZP9992A

Clinical trials

46 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
46
registered trials across all phases
LATEST COMPLETION 2026
9
Active studies
7
Recruiting
34
Late-stage (III+)
28
Completed
9
Discontinued
PHASE DISTRIBUTIONn = 46
Early Phase 11Phase 12Phase 1 / 23Phase 26Phase 2 / 32Phase 38Phase 49Phase N / A15

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

10 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20172024
Most influential
Recent papers
Major research themes8
Magnesium4Cardiovascular Diseases1Communicable Diseases1Dendrites1Diet1Dietary Supplements1Hashimoto Disease1Hippocampus1
Journals, researchers & institutions
Top journals
  • Nature communications2
  • European journal of nutrition1
  • Frontiers in endocrinology1
  • International journal of molecular sciences1
  • Journal of health, population, and nutrition1
  • Journal of the American Heart Association1
Leading researchers
  • Adams SC1
  • Alateeq K1
  • Ambikairajah A1
  • Ashique S1
  • Ayers P1
  • Berdahl GJ1
  • Bi GQ1
  • Blanchard A1
Leading institutions
free-text, unnormalised
  • School of Pharmacy2
  • Akron Children's Hospital1
  • Amity Institute of Pharmacy1
  • Australian Research Centre in Complementary and Integrative Medicine1
  • Boston Children's Hospital1
  • Center for Molecular Medicine1

Related diseases

2 conditions

Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.

Related drugs

3 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 6 of the same disease areas as Magnesium in the shared literature.

6 shared diseases1 shared paper

Studied across 5 of the same disease areas as Magnesium in the shared literature.

5 shared diseases1 shared paper

Studied across 4 of the same disease areas as Magnesium in the shared literature.

4 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials